Previous 10 | Next 10 |
ST. LOUIS, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that the first patients have been successfully treated using its Magnetic Interventional Ablation Catheter, MAGiC™. ...
2023-12-29 15:30:56 ET More on Inspire Medical Systems Inspire Medical Systems: Time To Wake Up Inspire Medical Systems, Inc. (INSP) Q3 2023 Earnings Call Transcript Inspire Medical Systems, Inc. 2023 Q3 - Results - Earnings Call Presentation Inspire Medical ...
LEXINGTON, Ky. and ST. LOUIS, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, and Baptist Health Lexington, a leading health provider in Kentucky, today announced that physicians have built upon their...
ST. LOUIS, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Piper Sandler 35 th Annual Healthcare...
2023-11-12 06:48:07 ET Summary Stereotaxis was forced to do a human trial for its Magic catheter before it can get CE Mark. This is starting in a few weeks. Stereotaxis will soon submit a PMA for FDA approval of the Magic catheter 180 days after submission. China is set to app...
2023-11-09 14:42:06 ET Stereotaxis, Inc. (STXS) Q3 2023 Earnings Call Transcript November 09, 2023 10:00 AM ET Company Participants David Fischel - Chairman & Chief Executive Officer Kimberly Peery - Chief Financial Officer Conference Call Participants ...
2023-11-09 09:18:14 ET More on Stereotaxis Sizing Up Stereotaxis Stereotaxis Q3 2023 Earnings Preview Stereotaxis director acquires further indirect stake Seeking Alpha’s Quant Rating on Stereotaxis Historical earnings data for Stereotaxis ...
ST. LOUIS, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the third quarter ended September 30, 2023. “Stereotaxis continues to del...
2023-11-08 13:05:49 ET More on Stereotaxis Sizing Up Stereotaxis Stereotaxis director acquires further indirect stake Seeking Alpha’s Quant Rating on Stereotaxis Historical earnings data for Stereotaxis For further details see: Stereotaxis ...
ST. LOUIS, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the United States have been treated successfully utilizing Abbott’s EnSite...
News, Short Squeeze, Breakout and More Instantly...
ST. LOUIS, May 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac ...
ST. LOUIS, May 15, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive end...
ST. LOUIS, May 15, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024, scheduled to take place during Heart Rhythm S...